Armistice Capital, LLC 13D and 13G filings for Cyclo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-15 12:26 pm Purchase | 2025-06-30 | 13G | Cyclo Therapeutics, Inc. CYTH | Armistice Capital, LLC | 16,150,000 9.940% | 16,150,000 (New Position) | Filing |
| 2024-02-14 2:44 pm Purchase | 2023-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH | Armistice Capital, LLC | 1,501,625 4.990% | 471,625 (+45.79%) | Filing |
| 2023-02-14 12:30 pm Unchanged | 2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH | Armistice Capital, LLC | 1,030,000 10.830% | 0 (Unchanged) | Filing |
| 2023-02-10 4:28 pm Purchase | 2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH | Armistice Capital, LLC | 1,030,000 10.800% | 814,674 (+378.34%) | Filing |
| 2020-12-10 7:48 pm Purchase | 2020-12-08 | 13G | Cyclo Therapeutics, Inc. CYTH | Armistice Capital, LLC | 215,326 4.990% | 215,326 (New Position) | Filing |